Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology

BackgroundWith the emergence of disease-modifying therapies for Alzheimer’s disease (AD), there is an urgent need for scalable, accurate, and well-validated blood test alternatives to positron emission topography (PET) and lumbar punctures for identifying amyloid pathology to facilitate identificati...

Descrición completa

Detalles Bibliográficos

Principais autores:	David Wilson, Meenakshi Khare, Gallen Triana-Baltzer, Michele Wolfe, Patrick Sheehy, Karen Copeland, Lyndal Hesterberg, Ann-Jeanette Vasko, Wiesje M. van der Flier, Inge M. W. Verberk, Charlotte E. Teunissen, Mike Miller
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Neurology
Assuntos:	Alzheimer’s disease immunoassay p-Tau 217 validation amyloid Simoa
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1568971/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!